Skip to content
The Policy VaultThe Policy Vault

Inqovi (decitabine and cedazuridine tablets) — Cigna

Myelodysplastic Syndrome With Myeloproliferative Neoplasm Overlap Syndrome

Initial criteria

  • Patient age ≥ 18 years

Reauthorization criteria

  • Patient continues to meet initial criteria

Approval duration

1 year